Vicki Geiser

405 total citations
11 papers, 346 citations indexed

About

Vicki Geiser is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Vicki Geiser has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Immunology and 3 papers in Oncology. Recurrent topics in Vicki Geiser's work include T-cell and Retrovirus Studies (9 papers), Herpesvirus Infections and Treatments (9 papers) and Viral-associated cancers and disorders (3 papers). Vicki Geiser is often cited by papers focused on T-cell and Retrovirus Studies (9 papers), Herpesvirus Infections and Treatments (9 papers) and Viral-associated cancers and disorders (3 papers). Vicki Geiser collaborates with scholars based in United States. Vicki Geiser's co-authors include Clinton Jones, Yange Zhang, Melissa Inman, Clinton Jones, Sandra Pérez, Yunquan Jiang, Florencia Meyer, Gail Henderson, Joe Zhou and Elliott Kieff and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of General Virology.

In The Last Decade

Vicki Geiser

11 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki Geiser United States 10 280 214 74 65 45 11 346
Yunquan Jiang United States 13 206 0.7× 153 0.7× 232 3.1× 56 0.9× 44 1.0× 13 462
Pieter Admiraal Netherlands 8 157 0.6× 103 0.5× 152 2.1× 20 0.3× 43 1.0× 10 459
Yvonne K. Gruijthuijsen Netherlands 9 324 1.2× 131 0.6× 62 0.8× 35 0.5× 6 0.1× 10 459
Lambert C. Loh Canada 14 254 0.9× 175 0.8× 128 1.7× 8 0.1× 8 0.2× 24 414
Wendy Mears Canada 5 281 1.0× 128 0.6× 193 2.6× 49 0.8× 8 0.2× 6 435
Tarik M. Soliman United States 8 194 0.7× 185 0.9× 217 2.9× 29 0.4× 22 0.5× 10 435
Amanda G. Blouin United States 9 94 0.3× 50 0.2× 72 1.0× 54 0.8× 25 0.6× 15 299
Iain M. Kennedy United Kingdom 11 183 0.7× 76 0.4× 294 4.0× 19 0.3× 17 0.4× 14 444
Julienne Jagdeo Canada 8 89 0.3× 82 0.4× 225 3.0× 9 0.1× 15 0.3× 9 376
Y Akiyama Japan 5 216 0.8× 88 0.4× 115 1.6× 5 0.1× 33 0.7× 8 375

Countries citing papers authored by Vicki Geiser

Since Specialization
Citations

This map shows the geographic impact of Vicki Geiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Geiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Geiser more than expected).

Fields of papers citing papers by Vicki Geiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Geiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Geiser. The network helps show where Vicki Geiser may publish in the future.

Co-authorship network of co-authors of Vicki Geiser

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Geiser. A scholar is included among the top collaborators of Vicki Geiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Geiser. Vicki Geiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Geiser, Vicki, et al.. (2017). Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. Journal of Virology. 91(20). 15 indexed citations
2.
Geiser, Vicki, Ellen Cahir-McFarland, & Elliott Kieff. (2011). Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells. PLoS ONE. 6(8). e22929–e22929. 8 indexed citations
3.
Geiser, Vicki, et al.. (2008). Bovine herpesvirus type 1 induces cell death by a cell-type-dependent fashion. Microbial Pathogenesis. 44(6). 459–466. 31 indexed citations
4.
Zhang, Yange, Yunquan Jiang, Vicki Geiser, Joe Zhou, & Clinton Jones. (2006). Bovine herpesvirus 1 immediate-early protein (bICP0) interacts with the histone acetyltransferase p300, which stimulates productive infection and gC promoter activity. Journal of General Virology. 87(7). 1843–1851. 30 indexed citations
6.
Jones, Clinton, Vicki Geiser, Gail Henderson, et al.. (2005). Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Veterinary Microbiology. 113(3-4). 199–210. 65 indexed citations
7.
Geiser, Vicki & Clinton Jones. (2005). Localization of sequences within the latency-related gene of bovine herpesvirus 1 that inhibit mammalian cell growth. Journal of NeuroVirology. 11(6). 563–570. 16 indexed citations
8.
Geiser, Vicki, et al.. (2005). Analysis of a bovine herpesvirus 1 recombinant virus that does not express the bICP0 protein. Journal of General Virology. 86(7). 1987–1996. 21 indexed citations
9.
Geiser, Vicki & Clinton Jones. (2003). Stimulation of bovine herpesvirus-1 productive infection by the adenovirus E1A gene and a cell cycle regulatory gene, E2F-4. Journal of General Virology. 84(4). 929–938. 24 indexed citations
10.
Geiser, Vicki, Melissa Inman, Yange Zhang, & Clinton Jones. (2002). The latency-related gene of bovine herpesvirus-1 can inhibit the ability of bICP0 to activate productive infection. Journal of General Virology. 83(12). 2965–2971. 39 indexed citations
11.
Inman, Melissa, Yange Zhang, Vicki Geiser, & Clinton Jones. (2001). The zinc ring finger in the bICP0 protein encoded by bovine herpesvirus-1 mediates toxicity and activates productive infection. Journal of General Virology. 82(3). 483–492. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026